Baxter International Inc (BAX)vsIntuitive Surgical Inc (ISRG)
BAX
Baxter International Inc
$25.74
-2.28%
HEALTHCARE · Cap: $13.67B
ISRG
Intuitive Surgical Inc
$449.53
-2.14%
HEALTHCARE · Cap: $152.62B
Smart Verdict
WallStSmart Research — data-driven comparison
Baxter International Inc generates 0% more annual revenue ($11.61B vs $11.58B). ISRG leads profitability with a 25.5% profit margin vs -6.2%. ISRG appears more attractively valued with a PEG of 2.00. ISRG earns a higher WallStSmart Score of 58/100 (C).
BAX
Hold50
out of 100
Grade: D+
ISRG
Buy58
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+51.0%
Fair Value
$45.47
Current Price
$25.74
$19.73 discount
Margin of Safety
+77.2%
Fair Value
$1981.99
Current Price
$449.53
$1532.46 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 36.8% YoY
Strong operational efficiency at 33.3%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 26 of every $100 in revenue as profit
Revenue surging 21.7% year-over-year
Generating 1.1B in free cash flow
Areas to Watch
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
ROE of -11.1% — below average capital efficiency
Expensive relative to growth rate
Trading at 9.7x book value
Premium valuation, high expectations priced in
Earnings declined 23.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : BAX
The strongest argument for BAX centers on Price/Book, EPS Growth.
Bull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 25.5% and operating margin at 33.3%. Revenue growth of 21.7% demonstrates continued momentum.
Bear Case : BAX
The primary concerns for BAX are Altman Z-Score, Debt/Equity, PEG Ratio.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, Price/Book, P/E Ratio. A P/E of 52.2x leaves little room for execution misses.
Key Dynamics to Monitor
BAX profiles as a turnaround stock while ISRG is a growth play — different risk/reward profiles.
ISRG carries more volatility with a beta of 1.46 — expect wider price swings.
ISRG is growing revenue faster at 21.7% — sustainability is the question.
ISRG generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
ISRG scores higher overall (58/100 vs 50/100), backed by strong 25.5% margins and 21.7% revenue growth. BAX offers better value entry with a 51.0% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Baxter International Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.
Visit Website →Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?